Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Randhawa Simrat sold 26,530 Dianthus Therapeutics, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 2, 2026
On Jun 1, 2026, Randhawa Simrat (EVP, Head of R&D) sold 26,530 Dianthus Therapeutics, Inc. shares at an average US$90.62 for US$2.4M under a trading plan, leaving 4,000 shares. Filed Jun 2, 2026 (Form 4).
- Sold
- 26,530 shares
- Price
- US$90.62 average (US$89.72 to US$91.37)
- Value
- US$2.4M
- Holding after
- 4,000 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Head of R&D
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Option exercise | 3,998 | US$8.44 | 7,998 | Direct |
| Jun 1, 2026 | Common Stock | Option exercise | 6,908 | US$17.88 | 14,906 | Direct |
| Jun 1, 2026 | Common Stock | Option exercise | 6,249 | US$21.77 | 21,155 | Direct |
| Jun 1, 2026 | Common Stock | Option exercise | 9,375 | US$22.07 | 30,530 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 5,428 | US$89.72 | 25,102 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 16,943 | US$90.72 | 8,159 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 4,159 | US$91.37 | 4,000 | Direct |
Source
Related
- Dianthus Therapeutics, Inc.
- Randhawa Simrat
- Dianthus Therapeutics, Inc. shareholders
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G · Wellington Management Group LLP · Aug 13, 2026